☰
×
News
Top 20
Insights
Insights+
ThoughtSpot
Interviews
Viewpoints
Exclusive
Spotlight
Events
Magazine
Bespoke
Newswire
x
Search
Search here
Search here
Subscribe Now
Asieris
Asieris Reports P-III Bridging Trial of Hexvix for the Treatment of Bladder Cancer
August 14, 2023
Asieris Reports the Completion of First Patient Dosing of Hexvix for the Treatment of Bladder Cancer
November 7, 2022
Asieris Reports World’s First Patient Dosing in P-I/II Study of Combination Regimen as a Neoadjuvant Therapy for MIBC Patients
January 4, 2022
PharmaShots Weekly Snapshots (October 11 - 15, 2021)
October 15, 2021
PharmaShots Weekly Snapshots (May 03 - 07, 2021)
May 7, 2021
Load more...
Back to Home
Modal title
×
Modal body text goes here.